US Patent Issued to Sanofi on Jan. 20 for "Selection marker-comprising cell line and uses thereof for protein production" (French Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,071, issued on Jan. 20, was assigned to Sanofi (Paris).

"Selection marker-comprising cell line and uses thereof for protein production" was invented by Bruno Louis Dumas (Paris) and Mohammed Nabil Lounis (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns a cell line comprising an endogenous dehydroorotate dehydrogenase (DHODH) gene which is partially or fully inactivated, and its use for producing recombinant proteins."

The patent was filed on March 19, 2020, under Application No. 17/440,728.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect...